C Are1, S Iacovitti, F Prete, F M Crafa. 1. Department of Surgery, Eppley Cancer Centre, Division of Surgical Oncology, University of Nebraska Medical Centre, Omaha, NE 68198, USA. chandrakanth@hotmail.com
Abstract
BACKGROUND: Patients noted to have an inadequate future liver remnant on pre operative volumetric assessment are considered to be candidates for portal vein embolization (PVE). A subset of patients undergo laparoscopic intervention prior to PVE for staging purposes or to address the primary in Stage IV colon cancer. These patients usually undergo PVE as a subsequent additional procedure by the transhepatic route. The aim of this study was to assess the feasibility of portal vein ligation by the laparoscopic approach in suitable patients. MATERIALS AND METHODS: A retrospective review of a prospectively maintained database was performed to identify patients that underwent laparoscopic portal vein ligation (LPVL). The demographic, clinical, radiographic, operative and volumetric details were collected to determine the feasibility of portal vein ligation. RESULTS: A total of nine patients underwent LPVL as part of a two stage procedure in preparation for subsequent major hepatectomy. With a median age of 67 yrs, the diagnoses included: colorectal metastasis (five patients), cholangiocarcinoma (three patients) and hepatocellular carcinoma (one patient). The ligation involved the right portal vein in all and was performed with silk ligature (seven patients) and clips (two patients). Volumetric data was available in six patients which showed a mean increase from 209.1 cc+/-97.76 to 495.83 cc+/-310.91 (increase by 181.5%) In two patients, inadequate hypertrophy mandated later embolization by percutaneous technique. Five patients underwent subsequent major hepatic resection as planned. The remaining four patients were noted to have progression of disease that precluded the planned procedure. There were no complications associated with LPVL. CONCLUSIONS: LPVL is feasible and can be safely performed. In a select group of patients, it may be considered as an alternative to subsequent embolization and thereby potentially absolve the need for an additional procedure with its attendant complications.
BACKGROUND:Patients noted to have an inadequate future liver remnant on pre operative volumetric assessment are considered to be candidates for portal vein embolization (PVE). A subset of patients undergo laparoscopic intervention prior to PVE for staging purposes or to address the primary in Stage IV colon cancer. These patients usually undergo PVE as a subsequent additional procedure by the transhepatic route. The aim of this study was to assess the feasibility of portal vein ligation by the laparoscopic approach in suitable patients. MATERIALS AND METHODS: A retrospective review of a prospectively maintained database was performed to identify patients that underwent laparoscopic portal vein ligation (LPVL). The demographic, clinical, radiographic, operative and volumetric details were collected to determine the feasibility of portal vein ligation. RESULTS: A total of nine patients underwent LPVL as part of a two stage procedure in preparation for subsequent major hepatectomy. With a median age of 67 yrs, the diagnoses included: colorectal metastasis (five patients), cholangiocarcinoma (three patients) and hepatocellular carcinoma (one patient). The ligation involved the right portal vein in all and was performed with silk ligature (seven patients) and clips (two patients). Volumetric data was available in six patients which showed a mean increase from 209.1 cc+/-97.76 to 495.83 cc+/-310.91 (increase by 181.5%) In two patients, inadequate hypertrophy mandated later embolization by percutaneous technique. Five patients underwent subsequent major hepatic resection as planned. The remaining four patients were noted to have progression of disease that precluded the planned procedure. There were no complications associated with LPVL. CONCLUSIONS: LPVL is feasible and can be safely performed. In a select group of patients, it may be considered as an alternative to subsequent embolization and thereby potentially absolve the need for an additional procedure with its attendant complications.
Authors: T Shimamura; Y Nakajima; Y Une; T Namieno; K Ogasawara; K Yamashita; T Haneda; K Nakanishi; J Kimura; M Matsushita; N Sato; J Uchino Journal: Surgery Date: 1997-02 Impact factor: 3.982
Authors: M D'Angelica; Y Fong; S Weber; M Gonen; R P DeMatteo; K Conlon; L H Blumgart; W R Jarnagin Journal: Ann Surg Oncol Date: 2003-03 Impact factor: 5.344
Authors: K Yamakado; K Takeda; K Matsumura; A Nakatsuka; T Hirano; N Kato; H Sakuma; T Nakagawa; Y Kawarada Journal: J Hepatol Date: 1997-11 Impact factor: 25.083
Authors: N Kokudo; K Tada; M Seki; H Ohta; K Azekura; M Ueno; K Ohta; T Yamaguchi; T Matsubara; T Takahashi; T Nakajima; T Muto; T Ikari; A Yanagisawa; Y Kato Journal: Hepatology Date: 2001-08 Impact factor: 17.425
Authors: Donatella R Di Stefano; Thierry de Baere; Alban Denys; Antoine Hakime; Gilles Gorin; Michel Gillet; Jean Saric; Hervé Trillaud; Philippe Petit; Jean-Michel Bartoli; Dominique Elias; Jean-Robert Delpero Journal: Radiology Date: 2004-12-10 Impact factor: 11.105
Authors: N J Lygidakis; Gurusharan Singh; E Bardaxoglou; G Dedemadi; G Sgourakis; J Nestoridis; A Malliotakis; M Pedonomou; E K Solomou; M Safioleas; Maria Alamani; L Grigorakos; E M Merikas Journal: Hepatogastroenterology Date: 2004 Mar-Apr
Authors: B Aussilhou; M Lesurtel; A Sauvanet; O Farges; S Dokmak; N Goasguen; A Sibert; V Vilgrain; J Belghiti Journal: J Gastrointest Surg Date: 2007-11-30 Impact factor: 3.452
Authors: Martin Zeile; Artur Bakal; Jan E Volkmer; Gregor A Stavrou; Philip Dautel; Jan Hoeltje; Axel Stang; Karl J Oldhafer; Roland Brüning Journal: Br J Radiol Date: 2016-10-12 Impact factor: 3.039
Authors: K P van Lienden; J W van den Esschert; W de Graaf; S Bipat; J S Lameris; T M van Gulik; O M van Delden Journal: Cardiovasc Intervent Radiol Date: 2012-07-18 Impact factor: 2.740
Authors: Giovanni Battista Levi Sandri; Lidia Colace; Giovanni Vennarecci; Roberto Santoro; Pasquale Lepiane; Marco Colasanti; Mirco Burocchi; Giuseppe Maria Ettorre Journal: Hepatobiliary Surg Nutr Date: 2015-10 Impact factor: 7.293
Authors: Giovanni Battista Levi Sandri; Roberto Santoro; Giovanni Vennarecci; Pasquale Lepiane; Marco Colasanti; Giuseppe Maria Ettorre Journal: Updates Surg Date: 2015-11-03
Authors: Julius Maximilian Plewe; Simon Wabitsch; Felix Krenzien; Philipp Haber; Timm Denecke; Bernhard Gebauer; Robert Öllinger; Johann Pratschke; Moritz Schmelzle Journal: J Minim Access Surg Date: 2019-01-04 Impact factor: 1.407